文献速递免疫规划

使用活标记疫苗「CP7_E2alf」预防中等毒力猪瘟病毒的胎盘传播

Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
PubMed 文献 · Vaccine · 2018-06-09

为评估活标记疫苗CP7_E2alf对猪瘟病毒胎盘传播的保护效果,按OIE陆生动物诊断试验与疫苗手册开展试验,8头妊娠母猪中6头于妊娠第44天肌注接种、2头不接种作为对照,所有母猪攻毒中等毒力猪瘟病毒株Roesrath后剖检。结果显示接种母猪及其胎儿血液中均未检出病毒,接种母猪胎儿血清中未检出抗体,对照成立。

要点

  • 6头妊娠母猪于妊娠第44天肌注接种CP7_E2alf,2头为不接种对照。
  • 所有母猪攻毒中等毒力猪瘟病毒株Roesrath后剖检。
  • 接种母猪及其胎儿血液未检出病毒,胎儿血清未检出抗体。

核心结论

  • 单剂接种CP7_E2alf可有效保护后代免受中等毒力猪瘟病毒株的胎盘感染。
  • 该疫苗符合OIE陆生动物诊断试验与疫苗手册的全部要求。

研究设计与样本

  • 按OIE陆生动物诊断试验与疫苗手册规定开展的试验,纳入8头妊娠母猪及其后代。
  • 6头母猪于妊娠第44天肌注接种CP7_E2alf,另2头为不接种对照。
  • 所有母猪攻毒中等毒力猪瘟病毒株Roesrath,于预计分娩日期前不久实施安乐死并剖检。

主要发现

  • 接种母猪及其胎儿血液中均未检出病毒。
  • 接种母猪所产胎儿血清中未检出抗体。
  • 所有对照均成立。

关键数值与推荐

  • 对接种母猪及胎儿的脾、扁桃体、淋巴结、肾脏、EDTA血和血清检测猪瘟病毒E2和Erns糖蛋白抗体及病毒、抗原和基因组。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Classical swine fever (CSF) remains as one of the most important infectious diseases of swine. While prophylactic vaccination is usually prohibited in free countries with industrialized pig production, emergency vaccination is still foreseen. In this context, marker vaccines are preferred as they can reduce the impact on trade. The live-attenuated Suvaxyn® CSF Marker vaccine by Zoetis (based on pestivirus chimera "CP7_E2alf"), was recently licensed by the European Medicines Agency. Its efficacy for the individual animal had been shown in prior studies, but questions remained regarding protection against transplacental transmission. To answer this question, a trial with eight pregnant sows and their offspring was performed as prescribed by the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Six of the sows were intramuscularly vaccinated on day 44 of gestation, while the other two remained as unvaccinated controls. All sows were challenged with the moderately virulent CSFV strain "Roesrath" and euthanized shortly before the calculated farrowing date. Sows and piglets were grossly examined and necropsied. Organs (spleen, tonsil, lymph node, and kidney), EDTA-blood and serum were collected from all animals. All samples were tested for antibodies against CSFV glycoproteins E2 and Erns as well as CSFV (virus, antigen and genome). It could be demonstrated that the vaccine complies with all requirements, i.e. no virus was found in the blood of vaccinated sows and their fetuses, and no antibodies were found in the serum of the fetuses from the vaccinated sows. All controls were valid. Thus, it was demonstrated that a single dose vaccination in the sows efficiently protected the offspring against transplacental infection with a moderately virulent CSFV strain.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Henke J, Carlson J, Zani L, et al. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf". Vaccine. 2018. PMID: 29895502. doi:10.1016/j.vaccine.2018.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。